Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-18

Clinical Trial Update: Frovatriptan as a Transitional Therapy in Medication Overuse Headache [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating frovatriptan as transitional therapy for medication overuse headache, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FROVATRIPTAN (FROVATRIPTAN SUCCINATE)

Snippet

Sponsor: University of Calgary | Conditions: Medication Overuse Headache, Analgesic Overuse Headache | Phase 2 | Status: COMPLETED